Erika Carmel-Tech Ltd - Asset Resilience Ratio
Erika Carmel-Tech Ltd (ERKA) has an Asset Resilience Ratio of 0.99% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ERKA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how Erika Carmel-Tech Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Erika Carmel-Tech Ltd.
Liquid Assets Composition Over Time
This chart breaks down Erika Carmel-Tech Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Erika Carmel-Tech Ltd carry for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA262.00K | 0.99% |
| Total Liquid Assets | ILA262.00K | 0.99% |
Asset Resilience Insights
- Limited Liquidity: Erika Carmel-Tech Ltd maintains only 0.99% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Erika Carmel-Tech Ltd Industry Peers by Asset Resilience Ratio
Compare Erika Carmel-Tech Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
SHE:300760 |
Medical Devices | 0.64% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Brainsway Ltd
NASDAQ:BWAY |
Medical Devices | 0.87% |
|
Tactile Systems Technology Inc
NASDAQ:TCMD |
Medical Devices | 5.59% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
Annual Asset Resilience Ratio for Erika Carmel-Tech Ltd (2022–2025)
The table below shows the annual Asset Resilience Ratio data for Erika Carmel-Tech Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.87% | ILA255.00K ≈ $683.65 |
ILA29.16 Million ≈ $78.17K |
-5.90pp |
| 2024-12-31 | 6.78% | ILA2.35 Million ≈ $6.31K |
ILA34.75 Million ≈ $93.16K |
-10.84pp |
| 2023-12-31 | 17.61% | ILA8.26 Million ≈ $22.15K |
ILA46.91 Million ≈ $125.76K |
-1.31pp |
| 2022-12-31 | 18.92% | ILA12.94 Million ≈ $34.69K |
ILA68.39 Million ≈ $183.34K |
-- |
About Erika Carmel-Tech Ltd
Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. T… Read more